<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>5(8)</volume><submitter>Voigt A</submitter><pubmed_abstract>Alteration and/or mutations of the ribonucleoprotein TDP-43 have been firmly linked to human neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). The relative impacts of TDP-43 alteration, mutation, or inherent protein function on neural integrity, however, remain less clear--a situation confounded by conflicting reports based on transient and/or random-insertion transgenic expression. We therefore performed a stringent comparative investigation of impacts of these TDP-43 modifications on neural integrity in vivo. To achieve this, we systematically screened ALS/FTLD-associated and synthetic TDP-43 isoforms via same-site gene insertion and neural expression in Drosophila; followed by transposon-based motor neuron-specific transgenesis in a chick vertebrate system. Using this bi-systemic approach we uncovered a requirement of inherent TDP-43 RNA-binding function--but not ALS/FTLD-linked mutation, mislocalization, or truncation--for TDP-43-mediated neurotoxicity in vivo.</pubmed_abstract><journal>PloS one</journal><pagination>e12247</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC2923622</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>TDP-43-mediated neuron loss in vivo requires RNA-binding activity.</pubmed_title><pmcid>PMC2923622</pmcid><pubmed_authors>Fiesel FC</pubmed_authors><pubmed_authors>Schulz JB</pubmed_authors><pubmed_authors>Karsten P</pubmed_authors><pubmed_authors>Kahle PJ</pubmed_authors><pubmed_authors>Voigt A</pubmed_authors><pubmed_authors>Weber SS</pubmed_authors><pubmed_authors>Kaur K</pubmed_authors><pubmed_authors>Marquardt T</pubmed_authors><pubmed_authors>Muller D</pubmed_authors><pubmed_authors>Herholz D</pubmed_authors></additional><is_claimable>false</is_claimable><name>TDP-43-mediated neuron loss in vivo requires RNA-binding activity.</name><description>Alteration and/or mutations of the ribonucleoprotein TDP-43 have been firmly linked to human neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). The relative impacts of TDP-43 alteration, mutation, or inherent protein function on neural integrity, however, remain less clear--a situation confounded by conflicting reports based on transient and/or random-insertion transgenic expression. We therefore performed a stringent comparative investigation of impacts of these TDP-43 modifications on neural integrity in vivo. To achieve this, we systematically screened ALS/FTLD-associated and synthetic TDP-43 isoforms via same-site gene insertion and neural expression in Drosophila; followed by transposon-based motor neuron-specific transgenesis in a chick vertebrate system. Using this bi-systemic approach we uncovered a requirement of inherent TDP-43 RNA-binding function--but not ALS/FTLD-linked mutation, mislocalization, or truncation--for TDP-43-mediated neurotoxicity in vivo.</description><dates><release>2010-01-01T00:00:00Z</release><publication>2010 Aug</publication><modification>2021-02-27T08:30:54Z</modification><creation>2019-03-26T23:08:54Z</creation></dates><accession>S-EPMC2923622</accession><cross_references><pubmed>20806063</pubmed><doi>10.1371/journal.pone.0012247</doi></cross_references></HashMap>